Home/Filings/4/0001062993-25-010576
4//SEC Filing

Azarbarzin Kurt 4

Accession 0001062993-25-010576

CIK 0001561921other

Filed

May 29, 8:00 PM ET

Accepted

May 30, 4:17 PM ET

Size

7.2 KB

Accession

0001062993-25-010576

Insider Transaction Report

Form 4
Period: 2025-05-28
Transactions
  • Award

    Common Stock

    2025-05-28+7,95018,470 total
  • Award

    Stock Option (Right to Buy)

    2025-05-28+11,70011,700 total
    Exercise: $1.39Exp: 2035-05-28Common Stock (11,700 underlying)
Footnotes (2)
  • [F1]These restricted stock units vest on the earlier of (a) May 28, 2026, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date.
  • [F2]The option vests on the earlier of (a) May 28, 2026, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date.

Issuer

TELA Bio, Inc.

CIK 0001561921

Entity typeother

Related Parties

1
  • filerCIK 0001792303

Filing Metadata

Form type
4
Filed
May 29, 8:00 PM ET
Accepted
May 30, 4:17 PM ET
Size
7.2 KB